Ultra micro quantification of dopamine and homovanillic acid in human brain tissue: Quest for higher recovery and sensitivity with CoulArray HPLC-ECD system

Journal of Liquid Chromatography and Related Technologies

Volumn 29, Issue 6, 2006, Pages 777-799

  Kumar, Adarsh ^a   Fernandez, J ^a   Gonzalez, Louis ^a   Kumar, Mahendra ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Brain tissues; CoulArray HPLC ECD; Dopamine; HVA

Indexed keywords

BRAIN; DISEASES; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NEUROLOGY; TISSUE;

BRAIN TISSUES; COULARRAY HPLC-ECD; DOPAMINE; HVA;

CARBOXYLIC ACIDS;

CATECHOLAMINE; DOPAMINE; HOMOVANILLIC ACID;

AQUEOUS SOLUTION; ARTICLE; BRAIN HOMOGENATE; BRAIN REGION; BRAIN TISSUE; CALIBRATION; CATECHOLAMINE BRAIN LEVEL; COGNITIVE DEFECT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; COULOMETRY; DOPAMINE BRAIN LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN TISSUE; MICROELECTRODE; PROTEIN ANALYSIS; PROTEIN ISOLATION; QUANTITATIVE ANALYSIS; RELIABILITY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33644624772     PISSN: 10826076     EISSN: None     Source Type: Journal    
DOI: 10.1080/10826070500530245     Document Type: Article

References (33)

1. Previc, F.H. Dopamine and origin of human intelligence. Brain and Cognition, 1999, 41, 299-350.
2. Koob, G.F. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol. Sci. 1992, 13, 177-184.
3. Wise, R.A.; Rompre, P. Brain dopamine and reward. Ann. Rev. Psychol. 1994, 40, 191-225.
4. Schultz, W. Dopamine neurons and their role in reward mechanisms. Curr. Opin, Neurobiol. 1997, 7, 191-197.
5. Vollm, B.A.; Araujo, I.E.; Cowen, P.J.; Rolls, E.T.; Kringelbach, M.L.; Smith, K.A.; Jezzard, P.; Heal, R.J.; Matthews, P.M. Methamphetamine activates reward circuitry in drug naive human subjects Neuropsychopharmacology 2004, 29 (9), 1715-22.
6. Quarton, G.C., Melnechuck, T., Schmitt, F.O., Eds. The Neurosciences: A study program; Rockefeller University Press: New York, 1967; 962.
7. Carlsson, A.; Adolfsson, R.; Aquilonius, S.M.; Gottfries, C.G.; Oreland, L.; Svennerholm, L.; Winblad, B. Biogenic amines in human brain in normal aging, senile dementia, and chronic alcoholism. In Ergot Compounds and Brain Function: Neuroendocrine and Neuropsychiatric Aspects; Goldstein, M., Ed.; Raven Press: New York, 1980; 295-304.
8. Hornykiewicz, O.; Kish, S.J. Biochemical pathophysiology of Parkinsons's disease. Adv. Neurol. 1986, 45, 19-34.
9. Wilson, J.M.; Levey, A.I.; Rajput, A.; Ang, L.; Guttman, M.; Shannak, K. Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease. Neurobiology 1996, 47, 718-726.
10. Adolfsson, R.; Gottfries, C.G.; Roos, B.E.; Winblad, B. Postmortem distribution of dopamine and homovanillic acid in human brain. Variation related to age and a review of literature. J. Neural Trans. 1979, 45, 81-105.
11. Berger, J.R.; Kumar, M.; Kumar, A.M.; Fernandez, J.B.; Levin, B. Cerebrospinal fluid dopamine in HIV-1 infection. AIDS 1994, 8, 67-71.
12. Ellis, R.J.; Childers, M.E.; Kumar, A.M.; Kumar, M.; Goetz, T.; Caliguiri, M. Decreased CSF dopamine correlates with impaired motor skills in HIV-1 infection and methamphetamine dependence. Soc of Neuroscience Conf 34th Annual meeting, San Diego, CA, Oct. 2004.
13. Anton, A.H.; Sayre, D.F. A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamines. J. Pharmacol. Exp. Ther. 1962, 138, 360-375.
14. Carlsson, A.; Winblad, B. Influence of age and time interval between death and autopsy in dopamine and 3-hydroxytyramine levels in human basal ganglia. J. Neural Trans. 1976, 38, 271-276.
15. Koslow, S.H.; Cattabeni, F.; Costa, E. Norepinephrine and dopamine: assay by mass fragmentography in the picomole range. Science 1972, 176 (31), 177-180.
16. Koslow, S.H.; Racagni, G.; Costa, E. Mass Fragmentographic measurement of norepinephrine, dopamine, serotonin, and acetylcholine in seven discrete nuclei of the rat Tel-Diencephalon. Neuropharmacol. 1974, 13, 1123-1130.
17. Kissinger, P.T.; Felice, L.J.; Riggin, R.M.; Pachla, L.A.; Wenke, D.C. Electrochemical detection of selected organic compounds in the eluate from high performance liquid chromatography. Clin. Chem. 1974, 20 (8), 992-997.
18. Refshauge, C.; Kissinger, P.T.; Dreiling, R.; Blank, L.; Freeman, R.; Adams, R.N. New high performance liquid chromatographic analysis of brain catecholamines. Life Sci. 1974, 14, 311-322.
19. Sasa, S.; Blank LeRoy, C. Determination of serotonin and dopamine in mouse brain tissue by high performance liquid chromatography with electrochemical detection. Anal. Chem. 1977, 49, 354-359.
20. Kumar, M.; Morgan, R.; Szapocznik, J.; Eisdorfer, C. Norepinephrine response in early HIV infection. J. Acq. Immunodefic Synd. 1991, 4, 782-786.
21. Kumar, A.M.; Kumar, M.; Fernandez, J.B.; Mellman, T.A.; Eisdorfer, C. A simplified HPLC-ECD technique for measurement of urinary free catecholamines. J. Liq. Chromatogr. 1991, 14 (19), 3547-3557.
22. Kumar, A.M.; Fernandez, J.B.; Schneiderman, N.; Goodkin, K.; Eisdorfer, C.; Kumar, M. Simultaneous determination of 5-hydroxytryptamine, 5-hydroxytryptophan, 5-hydroxyindoleacetic acid, dopamine, and homovanillic acid in whole blood using isocratic HPLC with electrochemical detection. J. Liq. Chromatogr. & Rel Technol. 1999, 22 (14), 2211-2223.
23. Kumar, A.M.; Fernandez, J.B.; Antonii, M.H.; Eisdorfer, S.; Kumar, M. Catecholamine quantification in body fluids using isocratic, reverse phase HPLC-CoulArray multi-electrode chemical detector system: Investigation of sensitivity, stability, and reproducibility. J. Liq. Chromatogr. & Rel. Technol. 2003, 26 (20), 3433-3451.
24. Hefti, F. A simple, sensitive method for measuring 3,4- dihydroxyphenylacetic acid and homovanillic acid in rat brain tissue using high-performance liquid chromatography with electrochemical detection. Life Sci. 1979, 25, 775-782.
25. Kempf, E.; Mandel, P. Reverse phase high performance liquid chromatographic separation and electrochemical detection of norepinephrine, dopamine, serotonin and related major metabolites. Anal. Biochem. 1981, 112, 223-231.
26. Wiley, C.A.; Masliah, E.; Morey, M.; Lemere, C.; DeTeresa, R.; Grafe, M.; Hansenl; Terry, R. Neocortical damage during HIV infection. Ann. Neurol. 1991, 29, 651-657.
27. Masliah, E.; Ge, N.; Morey, M.; DeTeresa, R.; Terry, R.D.; Wiley, C.A. Cortical dendritic pathology in human deficiency virus encephalitis. Lab. Invest. 1992, 66, 285-291.
28. Felice, L.; Felice, J.D.; Kissinger, P.T. Determination of catecholamines in rat brain parts by reverse-phase ion-pair liquid chromatography. J. Neurochem. 1978, 31, 1461-1465.
29. Keller, R.; Oke, A.; Mefford, I.; Adams, R.N. Liquid chromatography analysis of catecholamines: Routine assay for regional brain mapping. Life Sci. 1976, 19, 995-1004.
30. Walters, J.R.; Roth, R.H. Effect of gamma-hydroxybutyrate on dopamine and dopamine metabolites in the rat striatum. Biochem. Pharmacol. 1972, 21, 2111-2121.
31. Winblad, B.; Bucht, G.; Gottfries, C.G.; Roos, B.E. Monoamines and monoamine metabolites in brains from demented schizophrenics. Acta Psychiatr. Scandnav. 1979, 60, 17-28.
32. Nyberg, P.; Adolfsson, R.; Anden, N.E.; Winblad, B. Concentrations of dopamine and noradrenaline in some limbic related regions of the human brain. Acta Neurol. Scandinav. 1982, 65, 267-273.
33. Westerink, B.H.C.; Korf, J. Regional rat brain levels of 3,4 dihydroxyphenylacetic acid and homovanillic acid: concurrent fluorometric measurement and influence of drugs. European J. Pharmacol. 1976, 38, 281-291.